Bio-Rad Laboratories (BIO-B) Non Operating Income (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Non Operating Income data on file, last reported at $24.2 million in Q1 2026.

• Quarterly Non Operating Income fell 34.95% year-over-year to $24.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77.3 million (down 16.79% YoY) and the FY2025 annual result came in at $90.3 million, changed 0.0% from the prior year.
• Non Operating Income retreated to $24.2 million in Q1 2026 per BIO-B's latest filing, from $28.6 million in the prior quarter.
• Across five years, Non Operating Income topped out at $50.4 million in Q1 2023 and bottomed at $2.3 million in Q4 2022.
• The 5-year median for Non Operating Income is $19.1 million (2023), against an average of $20.9 million.
• Peak annual rise in Non Operating Income reached 7079.17% in 2022, while the deepest fall reached 76.85% in 2022.
• Tracing BIO-B's Non Operating Income over 5 years: stood at $2.3 million in 2022, then jumped by 719.39% to $19.1 million in 2023, then grew by 2.62% to $19.6 million in 2024, then surged by 45.92% to $28.6 million in 2025, then declined by 15.38% to $24.2 million in 2026.
• Per Business Quant, the three latest BIO-B Non Operating Income figures stand at $24.2 million (Q1 2026), $28.6 million (Q4 2025), and $8.3 million (Q3 2025).

Peer Comparison